Dec. 14, 2017 – At a drug pricing hearing held this week by the Senate Health, Education, Labor and Pensions Committee, a representative of the National Academies of Sciences told the panel that the cost of drug advertising must be factored into the price of a drug product, and that Congress should act to end […]
Read more
Dec. 4, 2017 – A new report from the National Academies of Science, Engineering and Medicine, “Making Medicines Affordable,” recommends promoting the adoption of industry codes of conduct, eliminating the tax deductibility of advertising expenses and discouraging direct-to-consumer (DTC) advertising in order to lower drug prices (http://bit.ly/2zX0jq7). “In yet another example of drug marketing being […]
Read more